EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond Bone Health: Exploring the “Heart–Brain–Bone” Axis Modulated by Lipid-Soluble Nutrients (Omega-3, Vitamin D3, and Vitamin K2)

Shih-Chin Fang iD, Meng-Kai Huang, Hsieh-Tsung Ethan Shen, Bo-Xiang Benjamin Zhang, Ting-Hsuan Collette Chao iD, Chung-Che Wu

Nutrients · 19.08.2026 · 18 (16) · 2711

DOI: 10.3390/nu18162711 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 19.08.2026. Verfasst von Shih-Chin Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Yonghe Cardinal Tien Hospital, New Taipei 234403, Taiwan. Hauptthemen laut MEDLINE: Vitamin K 2, Cholecalciferol, Fatty Acids, Omega-3, Bone and Bones. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Population aging is driving a convergent rise in three disorders historically managed in isolation: cardiovascular disease, neurocognitive decline, and osteoporotic bone loss. Mechanistic data indicate that these systems are coupled through shared regulators of calcium trafficking, inflammation resolution, vascular integrity, and inflammaging. On this basis, a “Heart–Brain–Bone” axis has been proposed; it should be understood as an integrative conceptual framework that organizes evidence drawn from three separate studies, not as a validated physiological entity with agreed diagnostic criteria or demonstrated modifiability. Three lipid-soluble nutrients—long-chain omega-3 polyunsaturated fatty acids (EPA/DHA), vitamin D3 (cholecalciferol), and vitamin K2 (menaquinone-7 [MK-7])—act on overlapping nodes of this network.

Methods

We performed a structured narrative review. PubMed/MEDLINE, Embase, the Cochrane Library, and Web of Science were searched from database inception to 25 June 2026 using predefined term blocks for each nutrient, each organ domain, and each candidate mechanism, and the search was updated on 7 August 2026. Records were screened against prespecified inclusion and exclusion criteria by two authors independently, with disagreements resolved by a third. The strength of evidence for each nutrient–organ relationship was graded with an explicitly defined four-level scheme ((−) to (+++)) applied separately to preclinical, observational, randomized and meta-analytic evidence.

Results

Vitamin K2-dependent gamma-carboxylation of matrix Gla protein (MGP) and osteocalcin has been proposed to influence whether calcium is incorporated into the bone matrix or deposited in the arterial wall, offering a candidate mechanistic account of the “calcium paradox” associated with isolated vitamin D3 supplementation; EPA/DHA-derived specialized pro-resolving mediators may support resolution of endothelial and neuronal inflammation; and bone-, vascular- and brain-derived signals (osteocalcin, FGF23, the neurovascular unit) interconnect the three organs. These mechanisms are biologically plausible but remain insufficiently confirmed in humans. The clinical evidence is heterogeneous, formulation- and population-dependent, and comprises positive, neutral and null results: cardiovascular omega-3 trials are discordant (REDUCE-IT, which used icosapent ethyl [an EPA ethyl ester], positive; VITAL/STRENGTH/ASCEND null, predominantly in lower-risk or replete cohorts); cognitive trials are largely null or subgroup-dependent (MAPT, DO-HEALTH, VITAL); and MK-7 improves surrogate bone and calcification biomarkers and slowed coronary artery calcification in one recent randomized imaging trial (VitaK-CAC), whereas combined MK-7 plus vitamin D3 did not slow aortic valve or coronary calcification in AVADEC and MK-7 did not reduce bone loss in early menopausal women. Recognized safety signals include a dose-dependent increase in atrial fibrillation with high-dose omega-3, adverse skeletal effects of high-dose or bolus vitamin D, and clinically relevant interference of even low-dose MK-7 with vitamin K antagonist therapy.

Conclusions

No adequately powered randomized trial has demonstrated that the combination of long-chain omega-3, vitamin D3 and MK-7 is superior to its individual components or to placebo for any clinical endpoint. The combined regimen is therefore mechanistically rational and hypothesis-generating rather than clinically established; benefit appears most plausible in individuals with elevated risk or demonstrable nutritional insufficiency, and least in replete, low-risk populations. Findings should be interpreted within a broader healthy-aging context that includes lifestyle and psychosocial factors. Adequately powered factorial randomized controlled trials stratified by baseline Omega-3 index, 25(OH)D and vitamin K status, with prespecified mechanistic biomarkers and hard endpoints, are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin K 2CholecalciferolFatty Acids, Omega-3Bone and BonesBrainHeartHumansMatrix Gla ProteinOsteocalcinExtracellular Matrix ProteinsFemaleAnimalsCardiovascular DiseasesOsteoporosisAging

Stichwörter der Autor:innen

Heart–Brain–Bone axisbone mineralizationinflammagingmatrix Gla proteinnarrative reviewomega-3 fatty acidsspecialized pro-resolving mediatorsvascular calcificationvitamin D3vitamin K2 (menaquinone-7)

Substanzen

Vitamin K 2CholecalciferolFatty Acids, Omega-3Matrix Gla ProteinOsteocalcinExtracellular Matrix Proteinsmenaquinone 7BGLAP protein, human

Autor:innen und Institutionen

  • Department of Neurology, Yonghe Cardinal Tien Hospital, New Taipei 234403, Taiwan.
  • X-Source Clinic, Taipei 115, Taiwan.
  • Master Program in School of Dental Technology, Taipei Medical University, Taipei 11031, Taiwan.
  • Sheng Hou Clinic, Taipei 10674, Taiwan.
  • YD Bio Limited, Taipei 115603, Taiwan.
  • Division of Clinical Cariology and Endodontology, Department of Oral Rehabilitation, School of Dentistry, Health Sciences University of Hokkaido, Tobetsu 061-0293, Japan.

ORCID-Profile: Shih-Chin Fang, Ting-Hsuan Collette Chao

Zitieren

APA

Fang, S. C., Huang, M. K., Shen, H. E., Zhang, B. B., Chao, T. C., & Wu, C. C. (2026). Beyond Bone Health: Exploring the “Heart–Brain–Bone” Axis Modulated by Lipid-Soluble Nutrients (Omega-3, Vitamin D3, and Vitamin K2). Nutrients, 18(16), 2711. https://doi.org/10.3390/nu18162711

Vancouver

Fang SC, Huang MK, Shen HE, Zhang BB, Chao TC, Wu CC. Beyond Bone Health: Exploring the “Heart–Brain–Bone” Axis Modulated by Lipid-Soluble Nutrients (Omega-3, Vitamin D3, and Vitamin K2). Nutrients. 2026;18(16):2711. doi:10.3390/nu18162711

BibTeX
@article{Fang2026,
  author = {Fang, Shih-Chin and Huang, Meng-Kai and Shen, Hsieh-Tsung Ethan and Zhang, Bo-Xiang Benjamin and Chao, Ting-Hsuan Collette and Wu, Chung-Che},
  title = {Beyond Bone Health: Exploring the “Heart–Brain–Bone” Axis Modulated by Lipid-Soluble Nutrients (Omega-3, Vitamin D3, and Vitamin K2)},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {16},
  pages = {2711},
  doi = {10.3390/nu18162711}
}
Kostenlos starten →